• Waki Nakajima, Mai Hatano, Yohei Ohtani, Hideaki Tani, Taisuke Yatomi, Shohei Tsuchimoto, Yu Fujimoto, Tsuyoshi Eiro, Sadamitsu Ichijo, Kotaro Nakano, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Hiroki Abe, Akane Sano, Kie Nomoto-Takahashi, Kengo Yonezawa, Sota Tomiyama, Nobuhiro Nagai, Keisuke Kusudo, Shiori Honda, Sotaro Moriyama, Shinichiro Nakajima, Takashige Yamada, … Takuya Takahashi
  The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression
  Molecular Psychiatry, doi.org/10.1038/s41380-026-03510-w, March 05, 2026.
  
• Yu Fujimoto, Hiroki Abe, Tsuyoshi Eiro, Sakiko Tsugawa, Meiro Tanaka, Mai Hatano, Waki Nakajima, Sadamitsu Ichijo, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Akane Sano, Koichi Hirahata, Nobuyuki Sasaki, Yuichi Kimura and Takuya Takahashi
  Systemic increase of AMPA receptors associated with cognitive impairment of long COVID
  Brain Communications, Volum 7 (5). doi.org/10.1093/braincomms/fcaf337 01 October, 2025.
  
• Yohei Ohtani MD, PhD, Hideaki Tani MD, PhD, Kie Nomoto-Takahashi MD, Taisuke Yatomi MD, Kengo Yonezawa MD, Sota Tomiyama MA, Nobuhiro Nagai MD, PhD, Keisuke Kusudo MD, Shiori Honda MS, PhD, Sotaro Moriyama MD, Shinichiro Nakajima MD, PhD, Takashige Yamada MD, PhD, Hiroshi Morisaki MD, PhD, Yu Iwabuchi MD, PhD, Masahiro Jinzaki MD, PhD, Kimio Yoshimura MD, PhD, Tsuyoshi Eiro MD, PhD, Sakiko Tsugawa MD, Sadamitsu Ichijo MD, PhD, Yu Fujimoto MD, Tomoyuki Miyazaki MD, PhD, Takuya Takahashi MD, PhD, Hiroyuki Uchida MD, PhD
  Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial
  Psychiatry and Clinical Neurosciences. doi:10.1111/pcn.13734 Aug 30, 2024.